Trial · NCT07883876
Comparative Effectiveness of Ultrasound-Guided Tenoxicam and Corticosteroid Injections for Lateral Epicondylitis
NCT07883876, Not applicable, Not yet recruiting, Ankara Etlik City Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparative Effectiveness of Ultrasound-Guided Tenoxicam and Corticosteroid Injections for Lateral Epicondylitis. Trials, record NCT07883876. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07883876
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparative Effectiveness of Ultrasound-Guided Tenoxicam and Corticosteroid Injections for Lateral Epicondylitis
- NCT number
- NCT07883876
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 72 participants, estimated
- Lead sponsor
- Ankara Etlik City Hospital
- Conditions
- Lateral Epicondylitis
- Interventions
- methylprednisolone acetate, tenoxicam
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline in Activity-Related Pain Intensity (VAS) at 12 Weeks | Baseline and 12 weeks after injection | Activity-related pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity during activity. The primary outcome will be the change in activity-related VAS score from baseline to 12 weeks after injection, calculated as the 12-week score minus the baseline score. Negative values indicate a reduction in activity-related pain. |
| Secondary | Change From Baseline in Upper Extremity Disability (QuickDASH) at 12 Weeks | Baseline and 12 weeks after injection | Upper extremity disability and function will be assessed using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. Scores range from 0 (no disability) to 100 (most severe disability). The change in QuickDASH score will be calculated as the 12-week score minus the baseline score. Negative values indicate an improvement in upper extremity function. |
| Secondary | Change From Baseline in Lateral Epicondylitis-Related Pain and Disability (PRTEE) at 12 Weeks | Baseline and 12 weeks after injection. | Pain and functional disability related to lateral epicondylitis will be assessed using the Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire. The total score ranges from 0 (no pain or disability) to 100 (maximum pain and disability). The change in PRTEE score will be calculated as the 12-week score minus the baseline score. Negative values indicate an improvement in pain and functional disability. |
| Secondary | Change From Baseline in Pain-Free Grip Strength (Jamar Dynamometer) at 12 Weeks | Baseline and 12 weeks after injection | Pain-free grip strength will be measured using a Jamar hand dynamometer and recorded in kilograms (kg). The maximum grip strength achieved without eliciting pain will be recorded. The change in pain-free grip strength will be calculated as the 12-week value minus the baseline value. Positive values indicate an improvement in pain-free grip strength. |
| Secondary | Change From Baseline in Common Extensor Tendon Thickness at 12 Weeks | Baseline and 12 weeks after injection | Common extensor tendon thickness will be measured in millimeters (mm) using ultrasonography at the lateral epicondyle region. The change in tendon thickness will be calculated as the 12-week measurement minus the baseline measurement. Negative values indicate a reduction in tendon thickness. |
| Secondary | Change From Baseline in Common Extensor Tendon Strain Ratio at 12 Weeks | Baseline and 12 weeks after injection | The mechanical properties of the common extensor tendon will be assessed using strain elastography. ROI 1 will be placed within the common extensor tendon, and ROI 2 within the subcutaneous fat tissue as the reference region. The strain ratio will be calculated as ROI 2 / ROI 1 (fat strain / tendon strain). Higher strain ratios indicate greater relative tendon stiffness. The change in strain ratio will be calculated as the 12-week value minus the baseline value. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07883876
GET https://conductscience.org/api/trials/v1/NCT07883876/registered